These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31552604)

  • 1. Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".
    McGettigan P; Olmo CA; Plueschke K; Castillon M; Zondag D; Bahri P; Kurz X; Mol PGM
    Drug Saf; 2019 Dec; 42(12):1517-1518. PubMed ID: 31552604
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".
    Jandhyala R
    Drug Saf; 2019 Dec; 42(12):1515-1516. PubMed ID: 31552605
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
    McGettigan P; Alonso Olmo C; Plueschke K; Castillon M; Nogueras Zondag D; Bahri P; Kurz X; Mol PGM
    Drug Saf; 2019 Nov; 42(11):1343-1351. PubMed ID: 31302896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
    McGettigan P; Alonso Olmo C; Plueschke K; Castillon M; Nogueras Zondag D; Bahri P; Kurz X; Mol PGM
    Drug Saf; 2019 Nov; 42(11):1353. PubMed ID: 31489581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TuberOus SClerosis Registry to Increase Disease Awareness: A Review on Alignment of Its Planning, Execution, and Publications With European Medicines Agency Guidelines.
    Marques R; Thole H; Ruiz de Morales JG
    Front Neurol; 2020; 11():365. PubMed ID: 32499750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.
    Meinel AB; Meinel MP
    Appl Opt; 1985 Apr; 24(7):944. PubMed ID: 20436652
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Comment on "Use of Patient Registries and Administrative Datasets for the Study of Pediatric Cancer".
    Rice HE
    Pediatr Blood Cancer; 2016 Feb; 63(2):368. PubMed ID: 26505755
    [No Abstract]   [Full Text] [Related]  

  • 8. A UK medical devices regulator's perspective on registries.
    Wilkinson J; Crosbie A
    Biomed Tech (Berl); 2016 Apr; 61(2):233-7. PubMed ID: 27096766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to: "Comment on 'Review of patient registries in dermatology'".
    DiMarco G; Hill D; Feldman SR
    J Am Acad Dermatol; 2016 Dec; 75(6):e243. PubMed ID: 27846977
    [No Abstract]   [Full Text] [Related]  

  • 10. Authors' reply to Beales.
    Staerk L; Lip GY
    BMJ; 2016 Jan; 532():i266. PubMed ID: 26790694
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on: Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry: reply.
    Olsen IC
    Rheumatology (Oxford); 2019 Oct; 58(10):1885-1886. PubMed ID: 31170288
    [No Abstract]   [Full Text] [Related]  

  • 12. MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY.
    Montilla S; Xoxi E; Russo P; Cicchetti A; Pani L
    Int J Technol Assess Health Care; 2015 Jan; 31(4):210-3. PubMed ID: 26646859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Authors' Reply.
    Hong JC; Salama JK
    J Natl Compr Canc Netw; 2019 Aug; 17(8):xxxixa-xl. PubMed ID: 31390591
    [No Abstract]   [Full Text] [Related]  

  • 14. Authors' reply.
    Turner R; Fiorella D; Mocco J; Frei D; Baxter B; Siddiqui A; Spiotta A; Chaudry I; Turk AS
    J Neurointerv Surg; 2016 Jun; 8(e1):e23. PubMed ID: 25335790
    [No Abstract]   [Full Text] [Related]  

  • 15. EURAP registry: inadequate monitoring of prescribed drugs in pregnancy - Authors' reply.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F
    Lancet Neurol; 2018 Sep; 17(9):741-742. PubMed ID: 30129470
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-discharge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: time for a change? Authors' reply.
    Niedziela JT; Strojek K; Gąsior M
    Kardiol Pol; 2020 May; 78(5):482-483. PubMed ID: 32458666
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic treatment strategies after PCI - Authors' reply.
    Vranckx P; Valgimigli M; Eckardt L; Gargiulo G; Goette A
    Lancet; 2020 Mar; 395(10227):867-868. PubMed ID: 32171407
    [No Abstract]   [Full Text] [Related]  

  • 18. Knee and hip replacements and the risk of revision - Authors' reply.
    Evans JT; Blom AW; Sayers A; Whitehouse MR
    Lancet; 2019 Aug; 394(10200):e31. PubMed ID: 31478507
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to antifungal medicines in resource-poor countries - authors' reply.
    Loyse A; Thangaraj H; Govender NP; Harrison T; Bicanic T;
    Lancet Infect Dis; 2014 May; 14(5):371. PubMed ID: 24758994
    [No Abstract]   [Full Text] [Related]  

  • 20. The Family Fund database--an underused research resource.
    Smithells RW
    Arch Dis Child; 1995 Aug; 73(2):182. PubMed ID: 7574872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.